| 10093624 |
NAMPT and ROCK inhibitors |
Rick F. Clark, Michael L. Curtain, Todd M. Hansen, Howard R. Heyman, Helmut Mack +7 more |
2018-10-09 |
$486,007,000 |
| 9957274 |
Indane inhibitors of EED and methods of their use |
Michael L. Curtin, Huan-Qiu Li, Marina Pliushchev, Ying Wang, Hongyu Zhao +7 more |
2018-05-01 |
$212,650,000 |
| 9796708 |
Pyrrolo [2,3-B] pyridine CDK9 kinase inhibitors |
Yunsong Tong, Milan Bruncko, Richard F. Clark, Michael L. Curtin, Alan S. Florjancic +17 more |
2017-10-24 |
$636,252,000 |
| 9302989 |
NAMPT and rock inhibitors |
Michael L. Curtin, Bryan K. Sorensen, Howard R. Heyman, Richard F. Clark, Kevin R. Woller +7 more |
2016-04-05 |
$168,990,000 |
| 9284272 |
Inhibitors of histone methyltransferase G9a |
Marina Pliushchev, Gary Chiang, William N. Pappano, Ramzi F. Sweis |
2016-03-15 |
$145,547,000 |
| 9193723 |
NAMPT inhibitors |
Richard F. Clark, Bryan K. Sorensen, Augustine Osuma, Robin Frey, Kenton L. Longenecker +7 more |
2015-11-24 |
$160,199,000 |
| 9187472 |
NAMPT inhibitors |
Richard F. Clark, Bryan K. Sorensen, Augustine Osuma, Robin Frey, Kenton L. Longenecker +7 more |
2015-11-17 |
$130,008,000 |
| 9051327 |
Pyridazino[4,5-D]pyrimidin-5(6H)-one inhibitors of kinases |
Gui-Dong Zhu, Jane Gong, Andrew S. Judd, Virajkumar B. Gandhi, Alexander R. Shoemaker +3 more |
2015-06-09 |
$60,924,000 |
| 8940778 |
Indazole, benzisoxazole, and benzisothiazole kinase inhibitors |
Yujia Dai, Steven K. Davidsen, Anna Ericsson, Kresna Hartandi, Zhiqin Ji |
2015-01-27 |
$84,369,000 |
| 8796289 |
Pyridazino[4,5-D]pyrimidin-5(6H)-one inhibitors of kinases |
Gui-Dong Zhu, Jane Gong, Andrew S. Judd, Virajkumar B. Ghandi, Alexander R. Shoemaker +3 more |
2014-08-05 |
$63,281,000 |
| 8722890 |
Thieno[3,2-C]pyridine kinase inhibitors with improved CYP safety profile |
Robin Frey, Michael L. Curtin |
2014-05-13 |
$104,935,000 |
| 8691810 |
Pyrrolopyridine and pyrrolopyrimidine inhibitors of kinases |
Andrew S. Judd, Shannon R. Fix-Stenzel, Richard F. Clark, Bryan K. Sorensen, Zhiqin Ji |
2014-04-08 |
$56,269,000 |
| 8642776 |
Indazole, benzisoxazole, and benzisothiazole kinase inhibitors |
Yujia Dai, Steven K. Davidsen, Anna Ericsson, Kresna Hartandi, Zhiqin Ji |
2014-02-04 |
$95,558,000 |
| 8436179 |
Kinase inhibitor with improved solubility profile |
Michael L. Curtin, James H. Holms, Douglas H. Steinman |
2013-05-07 |
$139,772,000 |
| 8426408 |
Pyrimidine inhibitors of kinases |
Michael L. Curtin, Howard R. Heyman, Robin Frey |
2013-04-23 |
$130,010,000 |
| 8299243 |
Indazole, benzisoxazole, and benzisothiazole kinase inhibitors |
Yujia Dai, Steven K. Davidsen, Anna Ericsson, Kresna Hartandi, Zhiqin Ji |
2012-10-30 |
|
| 8293738 |
Indazole inhibitors of kinase |
James H. Holms, Douglas H. Steinman |
2012-10-23 |
$37,169,000 |
| 8273736 |
Thienopyridine and furopyridine kinase inhibitors |
Patrick Betschmann, Andrew Burchat, David J. Calderwood, Michael L. Curtin, Steven K. Davidsen +9 more |
2012-09-25 |
$31,029,000 |
| 8124759 |
Inhibitors of protein kinases |
Zhiqin Ji |
2012-02-28 |
$51,945,000 |
| 8110572 |
Inhibitors of protein kinases |
Yujia Dai, Zhiqin Ji |
2012-02-07 |
$34,838,000 |
| 8063091 |
Indazole, benzisoxazole, and benzisothiazole kinase inhibitors |
Yujia Dai, Steven K. Davidsen, Anna Ericsson, Kresna Hartandi, Zhiqin Ji |
2011-11-22 |
$36,377,000 |
| 7829570 |
Substituted 4-amino isoxazolo[5,4-d]pyrimidines as kinase inhibitors |
Gavin Hirst, Andrew Burchat, Neil Wishart, David J. Calderwood, Zhiqin Ji |
2010-11-09 |
$38,765,000 |
| 7812166 |
Kinase inhibitors |
Yujia Dai, Kresna Hartandi |
2010-10-12 |
$27,565,000 |
| 7795248 |
Substituted 7,8-dihydro-1H-pyrimido[4,5-B][1,4]diazepin-4-amines are novel kinase inhibitors |
Vijaya J. Gracias, Celerino Abad-Zapatero, Stevan W. Djuric, Zhiqin Ji, Kent D. Stewart +1 more |
2010-09-14 |
$22,186,000 |
| 7737160 |
Thienopyridine and furopyridine kinase inhibitors |
Patrick Betschmann, Andrew Burchat, David J. Calderwood, Michael L. Curtin, Steven K. Davidsen +9 more |
2010-06-15 |
$56,407,000 |
